TBO-309
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TBO-309, covering 2025-11-25 to 2025-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke [Phase 2]